Starling is a 17-year-old male who suffers from hypopituitarism (E23.0), along with delayed puberty, adolescent idiopathic scoliosis of thoracolumbar region, and short stature due to an endocrine disorder. His most recent bone scan indicates he is greater than two standard deviations of the mean for his chronologic age. current TSH is 2.36, and Free T4 is 0.9. Starling has been on Genotropin for over a year and is showing improvement, forcing him to stop treatment in which he is currently experiencing clinical benefit is ill advised. Without this treatment, I fear he will fall further behind in growth, furthermore, without proper treatment, Starling may have life-long decreases in bone mineral density, abnormal body composition, increases
